Motley Fool Premium
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Dividend Stocks

    Steal These 3 Investing Tips From 1 of Canada’s Best Investors

    | Nelson Smith

    There are many lessons to be learned from Stephen Jarislowsky, one of Canada's greatest investors. Here's why he'd avoid Valeant…

    Read more »

    Investing

    3 Secular Trends Every Canadian Investor Should Know

    | Matt Smith

    Benefit from these secular trends by investing in BCE Inc. (TSX:BCE)(NYSE:BCE), Brookfield Renewable Energy Partners L.P. (TSX:BEP.UN)(NYSE:BEP), and Valeant Pharmaceuticals…

    Read more »

    The Motley Fool
    Investing

    Buy Valeant Pharmaceuticals Intl Inc. Now, or You’ll Regret it Later

    | Joseph Solitro

    Valeant Pharmaceuticals Intl Inc.’s (TSX:VRX)(NYSE:VRX) stock rose over 9% following the release of its second-quarter earnings results. Will the rally…

    Read more »

    The Motley Fool
    Investing

    Buy Valeant Pharmaceuticals Intl Inc. for Global Pharmaceutical Diversification

    | Jacob Donnelly

    Because of its acquisitions in China and the Middle East, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) can act as a globally…

    Read more »

    The Motley Fool
    Investing

    2 Reasons to Buy Valeant Pharmaceuticals Intl. Inc.

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl. Inc. (TSX:VRX)(NYSE:VRX) continues to rise in price and market cap, making it a great choice for your…

    Read more »

    The Motley Fool
    Dividend Stocks

    3 Diversified Stock Picks for Long-Term Investors

    | Joseph Solitro

    Looking for a long-term play? If so, Computer Modelling Group Ltd. (TSX:CMG), Extendicare Inc. (TSX:EXE), and Valeant Pharmaceuticals Intl. Inc.…

    Read more »

    The Motley Fool
    Investing

    Could the CEO of Valeant Pharmaceuticals Intl Inc. Be the Next Warren Buffett?

    | Jacob Donnelly

    Warren Buffett has grown his empire by buying great companies. The CEO of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is doing…

    Read more »

    The Motley Fool
    Investing

    Billionaire John Paulson Doubles Down on Valeant Pharmaceuticals Intl Inc.

    | Robert Baillieul

    Billionaire John Paulson owns $400 million of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Should you buy, too?

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Another Berkshire Hathaway?

    | Jacob Donnelly

    Based on Bill Ackman's logic, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is perpetually undervalued because the companies it buys consistently push…

    Read more »

    The Motley Fool
    Investing

    Deal-Making Valeant Pharmaceuticals Intl Inc. Shows No Signs of Slowing Down

    | Doug Watt

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) dominates the TSX’s health care group, but there are other stocks in the sector worth…

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Continue its Meteoric Rise?

    | Karen Thomas, MSc, CFA

    Here's why I'm not so optimistic about Valeant Pharmaceuticals Intl Inc. (TSX: VRX)(NYSE: VRX).

    Read more »

    The Motley Fool
    Investing

    Why Is Warren Buffett’s Right-Hand Man so Bearish on Valeant Pharmaceuticals Intl Inc.?

    | Nelson Smith

    Charlie Munger does not have nice things to say about Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). But is that enough of…

    Read more »